Joint statement Association for Accessible Medicines – Medicines for Europe ahead of 5th EU-U.S. Trade and Technology Council Ministerial meeting

26 January 2024

Court decision on Supplementary Protection Certificate (SPC) manufacturing waiver risks undermining its use

18 January 2024

Medicines for Europe and European Business Association propose priority steps to continue the EU integration of the Ukrainе’s pharmaceutical industry

15 January 2024

The European Union cannot jeopardise patient access to generic medicines through the Urban Wastewater Treatment Directive

8 January 2024

(Original in SK) How low pricing of generic and biosimilar drugs relates to their shortage

27 November 2023

OPEN LETTER: Members of the European Parliament and EU 27 Ministers of Health on the revision of the pharmaceutical legislation

8 November 2023

Now or never: Europe must seize the Pharma Legislation opportunity to ensure patient access to continuous innovation for existing medicines

7 November 2023

Reformed SPC regulation would enhance timely access to essential medicines

25 October 2023

A step forward for the secure supply of medicines and manufacturing and for public health

25 October 2023

New pricing models for generic medicines to ensure long-term sustainable competition in Europe

10 October 2023

Background: Price erosion of generic medicines over time as a […]